Some relief.. (Up nearly 18% as I type this).
ALLIANCE NEWS DETAIL
TOP NEWS: MEDICLINIC SHARES JUMP ON ABU DHABI REGULATORY CHANGE
[ 27 Apr 2017 08:21 ]
LONDON (Alliance News) - Shares in private healthcare business Mediclinic International PLC jumped Thursday morning following a reported regulatory change in Abu Dhabi, waiving co-payments for private medical treatment.
Shares in Mediclinic were up 11% at 810.00 pence Thursday, shortly after the market open, the best performer in the FTSE 100.
Mediclinic noted Thursday statements from the crown prince of Abu Dhabi. Crown Prince Mohamed bin Zayed Al Nahyan ordered the waiving of the 20% co-payment for holders of a Thiqa medical insurance card when receiving treatment at private healthcare facilities in Abu Dhabi. Mediclinic said it is awaiting precise details on these regulatory changes from the Health Authority of Abu Dhabi.
Mediclinic said it will continue to monitor the regulatory environment and the effect of these changes on its Middle East business. It operates six hospitals and 34 clinics in the UAE, and its Mediclinic Middle East business contributed 16% of revenue for its financial year ended in March.
By Hana Stewart-Smith;
[email protected]; @HanaSSAllNews
AND the Swiss regulatory update on 10th April ..
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.
10 April 2017
Swiss regulatory update
Mediclinic International plc, the international private healthcare group, today announces the following updates in the regulatory environment of Hirslanden, its operating platform in Switzerland.
In the Group's interim results announcement on 10 November 2016, Mediclinic stated that the canton of Zurich was considering a levy on the proportion of privately insured patients treated in listed hospitals, including Klinik Hirslanden, known as the VVG levy and that the Swiss national outpatient tariff ("TARMED") was still in revision.
On Monday, 10 April 2017, the Zurich Cantonal Parliament voted not to approve the proposed VVG levy.
On TARMED, the Swiss Federal Government has released proposed adjustments as a transitional solution whilst healthcare providers and funders continue to negotiate and agree a revised TARMED tariff structure. The government proposal is targeting annual savings of around CHF700m across the public and private outpatient sectors. Outpatient services contribute less than 20% of Hirslanden revenues. Due to its implementation date on 1 January 2018, the impact on Hirslanden is expected to be limited in the 2018 financial year (to 31 March 2018). Based on initial analyses of the complex proposal, the expected annualised impact on Hirslanden outpatient revenues could be around 10% before any mitigating actions are considered which could include improved utilisation and increased efficiencies.
The Zurich Cantonal Parliament has also approved an amendment to the cantonal hospital law, providing a legal basis for the cantonal government to create a list of interventions that in future should generally be treated as outpatient rather than inpatient services. The final list of interventions will be agreed following a working group review.
